AptarGroup Inc (ATR)

Investment Committee Summary

Investment Thesis

AptarGroup makes dispensing and sealing systems — pumps, valves, closures and delivery devices — for beauty, personal care, home care, prescription drug, consumer health-care, injectable, and food and beverage customers. It is packaging by classification but device manufacturing by economics: the pharmaceutical and injectable applications are qualified into customers' regulatory filings, which makes that revenue slow to win and slow to lose, while the beauty and home-care applications behave like ordinary consumer packaging and move with volumes and promotional cycles. An operating margin near 17% sits above what commodity conversion earns, which is the evidence for the qualification argument. At $124 — roughly 16x forward earnings — the shares are fairly valued against the triangulated value (-12%), with a twelve-month base target of $128. The deciding variable is mix: whether the regulated, device-like share of revenue grows fast enough to offset a slower consumer base, because that is the whole justification for a premium to packaging peers. Capital intensity is real and the company carries net debt of ~$1.2B. The most damaging risk is paying a premium multiple for a business whose growth increasingly comes from its lower-margin half.

Narrative drafted 2026-08-16 by claude-opus-5 under supervision; reviewed by Marinus 2026-08-16.

The dashboard below is the whole argument on one page: spot ($124) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Anti-Thesis (The Real Bear Case)

The bear mechanism is mix reversal plus multiple compression. If beauty and home-care volumes soften while customers de-stock, the ordinary packaging half shrinks and the fixed cost of a capital-intensive plant network is absorbed across fewer units; an operating margin near 17% slips toward what a commodity converter earns. The premium rating then has nothing left to defend, and the premium is where most of the downside lives, because the shares already trade above the triangulated value. Customers hold a slower but persistent lever as well: reformulating to a simpler closure, or dual-sourcing a qualified component once protection lapses, which takes out price rather than volume and is very hard to see in a quarterly print. The structural scenario carries a fifth of the weight with a target below the 52-week low. With net debt of ~$1.2B outstanding and capital spending that cannot easily be halted, a volume trough shows up in cash before it shows up in reported profit.

Key Debate

P/E Multiple explains 51% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

What the Market Is Pricing In

At the current price, the market pays 22.5× consensus forward EPS, vs the house DCF terminal 14.0×, and a peer median 11.6×. The house DCF sits 26% below spot, so the market is pricing in more than the house case — roughly 3.3pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily margin-driven.

Scenario Analysis

The scenario tree spans a structural 'Structural — Volume Decline / Substitution' downside ($61.61) to a 'Bull — Pricing + Re-Rate' bull case ($210); the probability-weighted blend (PWEV $128) is +3% versus spot.

Share-count charge: none applied. The probability-weighted value above is the gross per-share figure — no annual dilution is deducted — stock-based compensation runs at 1.1% of revenue; free cash flow net of SBC is $0.26B. SBC is therefore disclosed, not charged: read the per-share figures as before dilution.

Scenario rationale — the driver path behind every target:

• Structural — Volume Decline / Substitution (20%, $61.61). Structural impairment — volume substitution / destocking: earnings AND the multiple compress together. Target sits below the 52-week low by construction.
• Downturn — Destocking / Weak Volumes (18%, $100). Cyclical downturn — packaging volumes (containerboard/cans/labels) + GDP + input costs weakens for 1–2 years before normalising.
• Base — GDP-Linked Volumes + Pricing (34%, $136). Mid-cycle — normalised packaging volumes (containerboard/cans/labels) + GDP + input costs; disciplined capital allocation; steady returns.
• Growth — Sustainable-Packaging Mix (20%, $175). Upside — sustainable-mix + pricing lifts earnings above mid-cycle; the multiple expands modestly.
• Bull — Pricing + Re-Rate (8%, $210). Upside tail — sustained tight conditions or a structural re-rate on sustainable-mix + pricing.

Valuation Triangulation

Three weighted anchors — an intrinsic dcf, a scenario-weighted pwev and a monte carlo median (student-t + regime switching) — read them with their basis in mind. The Monte Carlo, the DCF terminal and any peer re-rate key off a market multiple, so they are not fully independent; only discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat three numbers as three independent votes.

The house blend DECLARES five anchor weights — DCF 35%, scenario PWEV 25%, Monte Carlo 15%, sum-of-parts 15%, peer re-rate 10%. For this name sum-of-parts, peer P/E re-rate are not computed, so 25% of the declared weight is redistributed across the anchors that exist — which is why the weights above differ from the declared ones. The fair value is unaffected by this disclosure; the blend has always worked this way.

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the outcome distribution

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $120 and 47% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (51% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 8.5%, 14.0x terminal FCF multiple → $91.96. This anchor is deliberately the heaviest (47%): it is the valuation least hostage to the current multiple regime.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median EV/Revenue multiple implies $58.22; the peer-median forward P/E is 11.6x, but the engine carries no P/E-implied price for this name (no forward-EPS basis at the peer step). A premium is only justified by superior growth/margins; otherwise it is multiple risk. Excluded from the weighted blend — shown only as a market cross-check.

Across all anchors the spread is 59% of the median — wide (genuine disagreement — the blend carries low valuation confidence).

Sensitivity

DCF/share — WACC × terminal multiple

DCF/share — revenue CAGR Δ × op-margin Δ

Tornado — DCF/share swing by driver (widest first)

Company lever — SoP/share vs Packaging (paper / plastic / metal) multiple (AI re-rating) (base 17.0x)

Peer Quality & Weighting

Quality-weighted forward P/E: 13.4× (simple median 11.6×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $102–$162, centre $129 (+4% vs spot); spot sits at the 37th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

That ratio compares triangulated upside against the probability-weighted bear target, not the extreme tail; with a leg missing it is withheld rather than computed from a magnitude. Bull case (Bull — Pricing + Re-Rate): $210.

Company Overview & Business Model

AptarGroup Inc — HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES. AptarGroup, Inc. offers a range of packaging, dispensing and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectables, and food and beverage markets. The company is headquartered in Crystal Lake, Illinois.

How it makes money.

Edge. Narrow moat — inferred from a 17% operating margin and the packaging (paper / plastic / metal) business model. Some pricing power / share stability; terminal multiple near the market.

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Capital intensity & shareholder returns (ESTIMATE)

Structural risk vs optionality (INFERENCE)

Industry Context — Materials — Packaging

This name sits in the Materials — Packaging cluster as a packaging (paper / plastic / metal) name. packaging volumes (containerboard/cans/labels) + GDP + input costs. Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: CCK (packaging (paper / plastic / metal)) · ATR (packaging (paper / plastic / metal)) · SON (packaging (paper / plastic / metal)) · SLGN (packaging (paper / plastic / metal)) · GEF (packaging (paper / plastic / metal)) · GPK (packaging (paper / plastic / metal))

Mapping note: name-level 'Structural — Volume Decline / Substitution' (20%) + 'Downturn — Destocking / Weak Volumes' (18%) map to cluster Volume Decline — Destocking / Substitution (38%); name-level 'Growth — Sustainable-Packaging Mix' (20%) + 'Bull — Pricing + Re-Rate' (8%) map to cluster Pricing + Sustainable-Mix Upside (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Volume Decline — Destocking / Substitution — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The packaging cycle is the shared macro driver. Driver — packaging volumes + GDP + input costs. Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Balance Sheet & Liquidity

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Free-Cash-Flow Quality

Accounting quality: SBC 1% of revenue; cash conversion (OCF/NI) 145% — cash-backed.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.24 vs analyst floor +0.01 → delta +0.23 (n=36 mgmt / 28 Q&A; 16th pctile across the S&P book, z -1.1).

Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).

News (last 365d, 369 articles): avg ticker sentiment +0.18 (bullish 30% / bearish 2%)

Consensus & Market Expectations

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Catalyst Calendar

• 2026-10-29 (~51d) — Quarterly earnings — est. EPS $1.46 (AV EARNINGS_CALENDAR)

Forecast Track Record

• EPS surprise: beat 100% of the last 8 quarters; average surprise +6.0%.
• Prior-forecast backtest (19 snapshots, 2026-07-21→2026-09-03): directional hit-rate 100%; mean predicted -3.9% vs realised -6.9%. Disconfirming track record is reported, not suppressed.

Catalyst Timeline

5 catalysts in the next 90 days (of 13 tracked). Importance 1–3; confidence 0–1.

_Sources: extended.catalysts, data/catalysts/.json, data/catalysts/macro.json, AV DIVIDENDS, opex 3rd-Friday calc.

Scenario Macro & Key Risks

Decision Rules (Machine-Checked)

Stance: Hold — 0 bullish / 0 bearish / 0 caution rules triggered of 6 evaluable (0 lacked data).

Machine-checked rules over disclosed inputs. The authored falsification triggers elsewhere in this report are analyst judgment and are NOT evaluated here. The stance is a portfolio-management signal and does not modify the published research rating.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

• Organic revenue growth / order backlog < flat-to-negative for two consecutive quarters (2 consecutive prints). Sustained demand rollover breaks the base case toward the recession scenario.
• FY revenue ($B) < 3.95 (next reported fiscal year). (rationale withheld pending re-authoring — frozen figure or verdict)
• Probability-weighted fair value (PWEV) at the next re-run < 124.34 (any scheduled re-run). (rationale withheld pending re-authoring — frozen figure or verdict)

Fact / Inference / Speculation

• FACT: Spot $124; 52-week range $102–$162; engine rating HOLD; house target $128 (+3%). (source: Alpha Vantage 2026-09-08, 9 September 2026)
• INFERENCE: Triangulated FV $110 (-12% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
• SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Conviction Score

Research Conviction measures the strength and quality of the research setup — input coverage, financial quality, valuation support, process agreement. It is NOT the probability that the recommendation succeeds; the forecast track record section is the evidence on that.

57.3/100 (confidence band 45.3–69.3), 58th percentile of 893 covered names (as of 2026-09-08). Weighted composite under config ros-1.20.0 — every component and its inputs below.

Score history: 61.5 → 61.8 → 61.6 → 61.7 → 59.4 → 59.7 → 59.6 → 59.6.

Probability-Weighted Return Profile

Horizon: 1 year — at this horizon CAGR equals total return by definition. Expected values are the probability-weighted sums over the full scenario set below.

The gross expected return is the probability-weighted scenario return (it reconciles to the gross PWEV); the diluted figure applies the SBC share-count charge and matches the published PWEV-based target.

Expected Alpha

Expected return minus the return this name is REQUIRED to deliver for its risk (1-year horizon). Constants are pre-registered (preregistered-static (amendment #2, 2026-07-29); not fitted to MCH outcomes).

A negative expected alpha does not change the rating — it says the expected return does not clear the risk-adjusted hurdle at today's price. Rating mechanics are unchanged by this section.

Probability Cross-Checks

Not authoritative. The scenario probabilities in this report are AUTHORED — a judgement about how the world might go, not a measurement. Nothing below modifies them, the target, the rating or any position size. These checks ask only whether anything outside our own model agrees with us; where it does not, that is information for the reader, not a correction we have quietly applied.

Authored set: 5 scenarios, probabilities summing to 1.0, mean target $128.35.

Factor Exposures

Cross-sectional percentiles over 893 covered names (style scores sector-demeaned; thematic = return-beta to the theme's proxy ETF). 50 = estate median.

Market interaction: correlation vs SPY +0.43, vs QQQ +0.30 (trailing ~1y daily returns).

Options Intelligence

Preferred structure: Covered Call. The selector reads the equity view (direction) and the volatility surface — nothing here re-prices the chain.

• range-bound with rich premium — harvest elevated vol against a holding (a covered call); an iron condor sells both wings if unhedged
• Direction neutral from the overlay conviction/rating (read-only input).
• IV/RV at the 72nd percentile of the cross-section → high vol bucket. This is the measure that selects the structure above: it ranks how rich this name's implied vol is against its own realised vol, relative to other names.
• Reported alongside and not used to select: this name's own ATM IV sits at the 50th percentile of its own month-end history (decile 6). The two measures disagree here — vol is high for this name by its own history while its options are not unusually rich against its realised vol. Where they diverge, the cross-sectional measure is the one acting.
• IV term structure is in contango (longer-dated richer, slope +2.9pp) — favour longer-dated ownership (LEAPS) or calendars that are long the cheaper front.

IV term structure (contango, slope +2.9pp): 38-DTE 25% · 73-DTE 29% · 164-DTE 28%

Economics copied verbatim from the options overlay (priced from the listed chain (EOD marks)); the selector does not re-price.

Alternatives: Iron Condor, Cash-Secured Put. IV rank shown via the name's own monthly IV history (advisory); structure selected on the cross-sectional IV/RV percentile. Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Position Sizing Framework

Model output for research and education only — not individualised investment advice. Position-sizing and stance figures are mechanical outputs of the disclosed rules and inputs; they do not consider any person's objectives, financial situation, or tax status.

Options Overlay

A defined-risk way to express the HOLD equity view. Chain as of 2026-09-08 — end-of-day marks — indicative, not executable quotes.

Market signals — ATM IV 24.9% (moderate regime) · expected move ±6.2% (2026-10-16) · put/call OI 0.59 · ATM Δ 0.51 / Θ -0.07 / ν 0.16 · next earnings 2026-10-29. Direction: NEUTRAL (implied return -11.8% to triangulated fair value $109.63).

Covered Call (if held) (Income / neutral) — Short 135 C · 2026-10-16 · premium $0.92 · yield 0.7% · priced from the listed chain (EOD marks)

Converts a near-fair holding into income by agreeing to sell at a higher strike — worth weighing when upside looks limited near fair value and being called away is acceptable. Illustrative — no outcome is implied or guaranteed.

Protective Collar (if held) (Hedge) — Long 110 P / Short 135 C · 2027-02-19 · net $3.07 · floor -12.0% · cap +9.0% · priced from the listed chain (EOD marks)

For a holder who wants to stay invested but cap risk: the sold call funds most of the protective put, fencing the position into a band — a way to ride out a de-rating without selling.

Indicative options structures — a defined-risk expression of the equity view, model-and-market illustrated from the last-close chain. NOT personalised advice or an executable quote; premiums, IV and greeks move intraday. Options carry the risk of total loss of premium. Not a registered financial adviser.

Rating Bridge

Rating = HOLD because:

• Probability-weighted scenario value implies +3% vs spot
• Monte Carlo median implies -4% vs spot
• DCF fair value implies -26% vs spot — but this is terminal-value sensitive (exit-multiple $91.96 vs Gordon $109, 19% apart), so it carries less weight
• Bear case (Structural — Volume Decline / Substitution) downside is -50% vs spot
• Net: the valuation anchor itself sits 11.8% below spot, so there is no reward leg to weigh against the bear case and the reward-to-risk ratio is withheld rather than computed off a negative upside. The rating is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Model Appendix

DCF — line items

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 7% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 8.5% · Σ PV(FCF) $2B + PV(terminal) $5B = EV $7B; − net debt $1.2B → equity $6B ÷ diluted shares $0.07B = $91.96/share (exit-multiple terminal).

• Gordon terminal at 2.5% → $109/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
• Incremental ROIC on the forecast capex ≈ 5% vs WACC 8.5% → below WACC — the incremental build is value-dilutive.

Peer set

Implied prices at the peer medians: EV/Rev → $58.22 (no P/E-implied price — no forward-EPS basis at the peer step).

Weighted fair-value math

Assumption Register

Sensitivity-ranked drivers (widest fair-value swing first): Op margin ±3pp (41.0); Terminal × ±15% (24.0); Revenue CAGR ±3pp (22.0); Capex intensity ±15% (19.0); WACC ±1pp (9.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Research Provenance

Load-Bearing Assumptions

DCF: WACC 8.5%, terminal multiple 14×, FY+5 revenue $4B. Triangulation leans 47% on DCF, 33% on PWEV, 20% on the Monte Carlo median.